Explore the top HIPAA compliance software solutions for healthcare and health tech companies in 2026. Compare features, ...

Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered ...

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, CEO: ...

A developmental screening tool may identify young children with SCD who are at risk for academic difficulties, a study found.

CTEM is a continuous approach that helps cybersecurity teams identify, prioritize, & validate exploitable risks using threat ...

Thank you, Maxime. Quarter-over-quarter, net income rose 12% from $31 million in the third quarter, driven by growth in net interest income, strength in customer fee income, lower provision for credit ...

Many development efforts still fall short of their intended impact. The reason is rarely a lack of ideas or ambition. More ...

My name is Stefanie Nacar, and I'm the Chief Communications Officer here at Agenus. Welcome to our webcast where we'll be ...

Learn to convert Kalshi's Super Bowl 60 percentages into betting odds. Understand $1.00 contracts, implied probability, and price discovery.

Onvansertib added to FOLFIRI/bev first-line standard of care regimen showed dose-dependent improvement in overall response rates and durability trends as measured by progression-free survival in patie ...

Dyne Therapeutics leverages its FORCE platform to target genetically driven muscle diseases. Read why I am bullish about DYN ...